LETTER TO THE EDITOR
Genetic Differences May Reflect Differences in Susceptibility to Vulvodynia in General or in Spontaneous Remission Propensity: A Response
Andrew T. Goldstein MD,
Andrew T. Goldstein MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Noel Kim PhD,
Noel Kim PhD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Lara J. Burrows MD,
Lara J. Burrows MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Irwin Goldstein MD,
Irwin Goldstein MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author
Andrew T. Goldstein MD,
Andrew T. Goldstein MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Noel Kim PhD,
Noel Kim PhD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Lara J. Burrows MD,
Lara J. Burrows MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author Irwin Goldstein MD,
Irwin Goldstein MD
Center For Vulvovaginal Disorders, Washington, DC, USA
Search for more papers by this author
First published: 27 January 2015
No abstract is available for this article.
References
- 1Foster DC, Hasday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol 1997; 89: 291–296.
- 2Hartmann D. Chronic vulvar pain from a physical therapy perspective. Dermatol Ther 2010; 23: 505–513.
- 3Bornstein J, Goldschmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 2004; 58: 171–178.
- 4Burrows LJ, Goldstein A. The treatment of vestibulodynia with topical estradiol and testosterone. Sex Med 2013; 1: 30–33.
